As per the annexure enclosed.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.3 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Rose Merc's board approved the allotment of 3,55,723 convertible warrants at Rs. 90 each (Rs. 80 premium) to 13 allottees — 1 promoter and 12 non-promoters — on a preferential basis, with total potential consideration of about Rs. 3.20 crore. The company has already received Rs. 80.04 lakh as the 25% upfront payment, with the balance 75% due upon conversion within 18 months. The board also accepted the resignation of a director from subsidiary Rahi Pakhle RM Private Limited, reclassifying it as an associate, and approved the sale of a 49% stake in Kaale and Rose Merc Advisors for Rs. 49,000, which similarly shifts to associate status. Additionally, the company completed a 48% acquisition in Abaca Care Private Limited (organic homeopathy healthcare) for Rs. 48,000, making it a new subsidiary, and appointed Vikas Phadnis as Advisor – Strategy and Growth.
The preferential warrant issue is a small fundraising exercise (under Rs. 3.5 crore) that could dilute equity once converted over the next 18 months. The restructuring is minor, with negligible financial impact given the tiny revenue and net worth of the entities involved. The healthcare acquisition and the high-profile advisor appointment signal a strategic pivot, though deal sizes are symbolic — overall impact on share price is likely to be limited.